C-MER Medical Holdings Limited (HKG:3309)
Hong Kong
· Delayed Price · Currency is HKD
1.770
-0.020 (-1.13%)
Jun 13, 2025, 4:08 PM HKT
C-MER Medical Holdings Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Jun '25 Jun 12, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Market Capitalization | 2,134 | 2,454 | 4,294 | 6,206 | 7,926 | 6,585 | |
Market Cap Growth | -42.85% | -42.85% | -30.80% | -21.70% | 20.36% | 25.03% | |
Enterprise Value | 2,242 | 2,506 | 4,228 | 6,137 | 7,673 | 6,197 | |
Last Close Price | 1.77 | 2.01 | 3.44 | 4.90 | 6.89 | 5.72 | |
PE Ratio | - | - | 69.27 | - | 362.56 | - | |
Forward PE | - | 34.42 | 34.42 | 34.42 | 34.42 | 34.42 | |
PS Ratio | 1.12 | 1.28 | 2.23 | 3.58 | 7.12 | 9.41 | |
PB Ratio | 1.13 | 1.30 | 2.15 | 3.11 | 5.93 | 5.08 | |
P/TBV Ratio | 2.03 | 2.33 | 4.12 | 5.94 | 7.03 | 5.73 | |
P/FCF Ratio | 17.14 | 19.71 | 17.48 | 81.81 | 301.86 | 84.32 | |
P/OCF Ratio | 7.54 | 8.67 | 11.89 | 37.64 | 54.89 | 60.09 | |
EV/Sales Ratio | 1.17 | 1.31 | 2.20 | 3.54 | 6.90 | 8.86 | |
EV/EBITDA Ratio | 6.56 | 12.38 | 20.72 | 66.50 | 127.82 | 152.60 | |
EV/EBIT Ratio | 17.53 | 19.45 | 33.95 | 1453.13 | 929.93 | - | |
EV/FCF Ratio | 18.01 | 20.13 | 17.21 | 80.90 | 292.22 | 79.35 | |
Debt / Equity Ratio | 0.23 | 0.23 | 0.18 | 0.23 | 0.35 | 0.19 | |
Debt / EBITDA Ratio | 1.28 | 1.28 | 1.05 | 1.98 | 3.01 | 2.20 | |
Debt / FCF Ratio | 3.52 | 3.52 | 1.48 | 5.97 | 17.96 | 3.14 | |
Asset Turnover | 0.70 | 0.70 | 0.68 | 0.71 | 0.62 | 0.51 | |
Inventory Turnover | 28.03 | 28.03 | 26.75 | 28.52 | 25.34 | 23.54 | |
Quick Ratio | 1.32 | 1.32 | 1.60 | 1.45 | 1.17 | 3.75 | |
Current Ratio | 1.56 | 1.56 | 1.85 | 1.63 | 1.83 | 4.01 | |
Return on Equity (ROE) | -5.58% | -5.58% | 4.33% | -2.77% | 1.23% | -0.78% | |
Return on Assets (ROA) | 2.95% | 2.95% | 2.75% | 0.11% | 0.29% | -0.10% | |
Return on Capital (ROIC) | 3.44% | 3.44% | 3.24% | 0.12% | 0.31% | -0.10% | |
Return on Capital Employed (ROCE) | 5.60% | 5.60% | 5.30% | 0.20% | 0.50% | - | |
Earnings Yield | -6.33% | -5.51% | 1.44% | -0.35% | 0.28% | -0.10% | |
FCF Yield | 5.83% | 5.07% | 5.72% | 1.22% | 0.33% | 1.19% | |
Dividend Yield | 1.13% | 1.00% | - | - | - | 0.35% | |
Payout Ratio | - | - | - | - | 105.06% | - | |
Buyback Yield / Dilution | 1.77% | 1.77% | -1.82% | -7.16% | -4.22% | -3.02% | |
Total Shareholder Return | 2.90% | 2.76% | -1.82% | -7.16% | -4.22% | -2.67% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.